Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

Market Analysis and Insights: Global Nanomedicine Market
The global Nanomedicine market size is projected to reach US$ 246.8 million by 2027, from US$ 155.5 million in 2020, at a CAGR of 6.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanomedicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanomedicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanomedicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanomedicine market.

Global Nanomedicine Scope and Market Size
Nanomedicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices

Segment by Application
oncology
Infectious diseases
Cardiology
Orthopedics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences